Liver fat content reduction reached approximately 80 percent at higher dose tiers an outcome that, researchers have observed, has redirected research interest toward the compound's potential in MASLD/MASH research contexts (PMID 38858523)
Lilly USA LLC is the only United States company with FDA-approved products containing tirzepatide identified under the trade names Zepbound and Mounjaro
Your provider will review your health history to determine if GLP-1 treatment is safe for you
Graham Lipkin, Consultant Nephrologist at Queen Elizabeth Hospital Birmingham, "Those who take tacrolimus/ciclosporin should have their levels checked." This additional monitoring is crucial when initiating GLP-1 therapy due to the potential for drug interactions
While both companies that have a monopoly on these drugs (Novo Nordisk and Eli Lilly) have enjoyed an incredible run-up from 2020 to 2024, both are now in a drawdown
The most important steps are eating enough protein, performing resistance training, avoiding extreme calorie restriction, staying hydrated, correcting nutrient gaps, and monitoring progress with a qualified provider
